University of São Paulo

Better Choice Research Partner, Aimia Pet HealthCo Inc., Signs R&D Partnership Agreement for Development of GLP1 Supplement for Pets

Retrieved on: 
星期三, 十一月 8, 2023
Faculty, NYSE, São Paulo, Federal University of Rio Grande do Sul, Obesity, Cat, Université de Montréal Faculty of Veterinary Medicine, Pet, Doctor of Philosophy, Rio, UNESP, APH, Veterinary medicine, MOU, Medical school, Faculty of Medicine, University of Colombo, University of São Paulo, UFRGS, Animal, University, Universidad, Overweight, Better Choice Parking, Pain management, GLP1, Dog, MS, Physiology, Medicine, Pharmacology, Anesthesia

TAMPA, Fla., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, and its research partner, Aimia Pet HealthCo Inc. (APH), today announced that APH has signed a memorandum of understanding (MOU) with Dr. Nadia Crosignani for the development of a GLP1 supplement for pets.

Key Points: 
  • TAMPA, Fla., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, and its research partner, Aimia Pet HealthCo Inc. (APH), today announced that APH has signed a memorandum of understanding (MOU) with Dr. Nadia Crosignani for the development of a GLP1 supplement for pets.
  • The MOU sets out the basis for Dr. Crosignani to commence research and development of a GLP1 supplement for use in companion animals.
  • In addition, Dr. Crosignani has a post-doctorate degree from UNESP, Faculty of Medicine, researching in the field of pain management.
  • We see the use of the GLP1 supplement as a significant opportunity for the pet health industry and are assembling top tier partners to help Better Choice and our brands, including Halo, become pioneers in this sector,” commented Mike Young, Chairman of the Board for Better Choice.

15316171 Canada Inc. Acquires Control of Over 5% of the Shares of Search Minerals Inc. and Intends to Seek Board and Management Changes

Retrieved on: 
星期四, 九月 7, 2023
REE, Communication, Petros Molyviatis, TSX Venture Exchange, British Columbia Securities Commission, BCSC, File, University of São Paulo, CAD, AGM, Mass meeting, Meeting, Jubilee Holdings Limited, Shareholder, Toyota Canada Inc., Government, New Board, Investment, Risk, National instrument, Mining, National Instrument 43-101, Management, Letter, News, Disruptive Behavior Disorders Rating Scale, Annual general meeting, Security (finance), Holding company, SEARCH

The Shareholder has beneficial ownership of and\or voting control and direction over an aggregate of 26,579,635 common shares (the "Shares"), representing approximately 6.38 % of the total issued and outstanding common shares of SEARCH.

Key Points: 
  • The Shareholder has beneficial ownership of and\or voting control and direction over an aggregate of 26,579,635 common shares (the "Shares"), representing approximately 6.38 % of the total issued and outstanding common shares of SEARCH.
  • In the Shareholder's view, the SEARCH Board is not an independent board, as George Molyviatis and Jocelyn Bennett are the principals of InCoR Holdings Limited.
  • which owns appropriately 95M shares or 22.92 %, and as per the Company's news release of March 6, 2023, Dr. David Dreisinger is also not independent.
  • The Shareholder is convinced that a new Board of Directors is critical to align the interests of shareholders and management.

Dr. Neil A. Gordon Honored as Keynote Speaker at International Plastic Surgery Conference in Brazil, 2023

Retrieved on: 
星期四, 六月 8, 2023
Yale University, The Retreat, Split Rock, Surgeon, Rhinoplasty, Head, Anatomy, SIMPO, American Academy, Research, Breast augmentation, Privacy, Harvard University, To Brazil!, American Academy of Facial Plastic and Reconstructive Surgery, Patient, University of São Paulo, Physician, Plasma, Paulo, Knowledge, Health, Conference, Sheraton Hotels and Resorts, Retreat, Safety, Australasian Academy of Facial Plastic Surgery, Dentistry, Medical device

WILTON, Conn., June 8, 2023 /PRNewswire-PRWeb/ -- Board-certified facial plastic surgeon Dr. Neil A. Gordon was honored to be invited and serve as a keynote speaker on March 10-11 at the 2023 International Plastic Surgery Symposium (SIMPO) in São Paulo, Brazil, at the Sheraton Hotel. SIMPO focuses on topics like anatomy and facial surgery, neck lift, surgical demonstrations, rhinoplasty, breast augmentation, and the discussion of intercurrences and complex cases.

Key Points: 
  • WILTON, Conn., June 8, 2023 /PRNewswire-PRWeb/ -- Board-certified facial plastic surgeon Dr. Neil A. Gordon was honored to be invited and serve as a keynote speaker on March 10-11 at the 2023 International Plastic Surgery Symposium (SIMPO) in São Paulo, Brazil, at the Sheraton Hotel.
  • Dr. Gordon was the keynote speaker and performed a live deep plane facelift,
    streamed to thousands of surgeons around the world, in Brazil at the SIMPO International Conference in 2023.
  • In 2021, Dr. Gordon was honored to be the sole speaker and presenter at the first "Deep Plane Brazil '' conference in Sao Paolo.
  • In March 2023, Dr. Gordon performed a live surgery at the SIMPO Conference before the Brazilian Plastic Surgery Society.

SIGGRAPH 2022 Moves Forward and Looks Back: The Frontiers and Retrospective Programs Showcase How Legacy Drives Innovation

Retrieved on: 
星期四, 八月 4, 2022
Computer graphics, Woman, Photography, Multimedia, Association, Intelligence, Industry, Computer, Algorithm, Robotics, University of Tokyo, Technology, Growth, AI, Emeritus, Artificial intelligence, ACM, Research, University of Illinois at Chicago, Meta, Virtual reality, Chicago, Frontiers, University of São Paulo, Program, SIGGRAPH, Archive, Simon Fraser University, INESC, ACM SIGGRAPH, News, Most, Fred Brooks, University, The arts, AR, Somatosensory system, Video game, Science, Engineering, Art

CHICAGO, Aug. 4, 2022 /PRNewswire/ -- SIGGRAPH 2022 highlights the many voices that have facilitated the evolution of computer graphics and interactive techniques. The Frontiers and Retrospective programs feature pioneers and industry experts in panels and workshops for a passionate look at untold stories, influential voices, emerging topics, and new breakthroughs. The 49th annual conference runs 8–11 August in person, and virtually 25 July–31 October 2022.

Key Points: 
  • The Frontiers and Retrospective programs feature pioneers and industry experts in panels and workshops for a passionate look at untold stories, influential voices, emerging topics, and new breakthroughs.
  • The Frontiers and Retrospective Programs at SIGGRAPH 2022 Showcase How Legacy Drives Innovation.
  • The Retrospective program brings together the pioneers and leaders who have enabled computer graphics to improve lives.
  • Access to the Retrospective and Frontiers programs at SIGGRAPH 2022 is available in person and online.

Ping An's AI-driven AskBob Doctor Earns Top Scores in Diabetes Management Competition

Retrieved on: 
星期二, 十二月 7, 2021
People, International Diabetes Federation, Universe People, Database, University of São Paulo, Peking University International Hospital, Tianjin Medical University, Insurance, Ribeirão, Technology, Hospital, Singapore, Metabolism, Central Hospital, Shanghai Sixth People's Hospital, Moyamoya disease, Ping'an, IDF, Hyperlipidemia, Hypertension, Patient, Efficiency, Lists of diseases, Singapore General Hospital, Head, Diabetes, Roger Hawkins (drummer), Diabetic nephropathy, Peking University, Department, Senior Consultant, University, Diabetic retinopathy, International, Huế Central Hospital, Diagnosis, Speech, AI, São Paulo, Artificial intelligence, American Association of Clinical Endocrinologists, Medical device, Health insurance, Pharmaceutical industry

The competition was jointly organized by the International Diabetes Federation (IDF), Ping An Smart City, Ping An Technology, Ping An Good Doctor, Peking University People's Hospital and Peking University International Hospital.

Key Points: 
  • The competition was jointly organized by the International Diabetes Federation (IDF), Ping An Smart City, Ping An Technology, Ping An Good Doctor, Peking University People's Hospital and Peking University International Hospital.
  • AskBob Doctor was manually operated by a Ping An representative.
  • After a thorough evaluation by the judges, AskBob Doctor scored 92.4 points on average while the endocrinologists' team scored 89.5 points.
  • In addition, AskBob Doctor's response speed was impressive: AskBob Doctor took just a few seconds to complete one case, while a human doctor took nearly 20 minutes.

Northwestern Medicine Launches New Center Using Artificial Intelligence and Machine Learning to Treat Cardiovascular Disease

Retrieved on: 
星期四, 六月 28, 2018
Heart Institute, University of São Paulo, University of São Paulo, Cardiovascular disease, Health, Medicine

CHICAGO, June 28, 2018 /PRNewswire-USNewswire/ --Northwestern Medicine Bluhm Cardiovascular Institute, the top-ranked cardiovascular program in Illinois for the last 10 consecutive years, is launching a first-of-its-kind center that utilizes artificial intelligence and machine learning to advance the study and treatment of cardiovascular disease.

Key Points: 
  • CHICAGO, June 28, 2018 /PRNewswire-USNewswire/ --Northwestern Medicine Bluhm Cardiovascular Institute, the top-ranked cardiovascular program in Illinois for the last 10 consecutive years, is launching a first-of-its-kind center that utilizes artificial intelligence and machine learning to advance the study and treatment of cardiovascular disease.
  • Dr. McCarthy said the new center, part of the Bluhm Cardiovascular Institute, will focus on harnessing the power of artificial intelligence (AI) and machine learning to improve diagnosis, treatment and research for cardiovascular disease.
  • "Artificial intelligence is the next frontier in breakthrough medicine, and Northwestern Medicine is leading the way by incorporating this emerging technology throughout its cardiovascular programs," said Dr. McCarthy.
  • Currently, Northwestern Medicine is working with four companies to explore new ways to apply AI to clinical cardiovascular care.